1. Home
  2. ASRT vs FCO Comparison

ASRT vs FCO Comparison

Compare ASRT & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • FCO
  • Stock Information
  • Founded
  • ASRT 1995
  • FCO 1991
  • Country
  • ASRT United States
  • FCO United Kingdom
  • Employees
  • ASRT N/A
  • FCO N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • FCO Investment Managers
  • Sector
  • ASRT Health Care
  • FCO Finance
  • Exchange
  • ASRT Nasdaq
  • FCO Nasdaq
  • Market Cap
  • ASRT 78.3M
  • FCO 80.3M
  • IPO Year
  • ASRT 1997
  • FCO N/A
  • Fundamental
  • Price
  • ASRT $0.85
  • FCO $5.98
  • Analyst Decision
  • ASRT Strong Buy
  • FCO
  • Analyst Count
  • ASRT 4
  • FCO 0
  • Target Price
  • ASRT $3.19
  • FCO N/A
  • AVG Volume (30 Days)
  • ASRT 327.3K
  • FCO 100.1K
  • Earning Date
  • ASRT 03-10-2025
  • FCO 01-01-0001
  • Dividend Yield
  • ASRT N/A
  • FCO 14.96%
  • EPS Growth
  • ASRT N/A
  • FCO N/A
  • EPS
  • ASRT N/A
  • FCO 0.43
  • Revenue
  • ASRT $125,763,000.00
  • FCO N/A
  • Revenue This Year
  • ASRT N/A
  • FCO N/A
  • Revenue Next Year
  • ASRT $1.84
  • FCO N/A
  • P/E Ratio
  • ASRT N/A
  • FCO $12.30
  • Revenue Growth
  • ASRT N/A
  • FCO N/A
  • 52 Week Low
  • ASRT $0.73
  • FCO $4.73
  • 52 Week High
  • ASRT $1.80
  • FCO $6.63
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 52.09
  • FCO 46.12
  • Support Level
  • ASRT $0.78
  • FCO $5.92
  • Resistance Level
  • ASRT $0.88
  • FCO $6.13
  • Average True Range (ATR)
  • ASRT 0.03
  • FCO 0.11
  • MACD
  • ASRT 0.01
  • FCO -0.02
  • Stochastic Oscillator
  • ASRT 68.20
  • FCO 14.37

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About FCO abrdn Global Income Fund Inc.

abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.

Share on Social Networks: